Anavo Therapeutics is a biotechnology company focused on the development of allosteric modulators for phosphatases, aiming to create a pipeline of novel therapeutics for various diseases.

Anavo Therapeutics

Bioqube Ventures is a specialist life sciences investment firm. We source, finance and develop innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.

Bioqube Ventures launched in 2020 its first independent fund “Bioqube Factory Fund I”.

… An early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.

… A fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. 

… A hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.

Bioqube Ventures

Fellowship opportunity! Do you have a scientific background, are you passionate about developing therapeutics and eager to learn more about what makes venture capital tick in biotech? Then this 6-month Fellowship program at Bioqube might be the right fit for you! Find out more in the description below ⤵️ #vc #biotech #fellowship

Exciting update from our portfolio company @Bicara Therapeutics at @ESMO !

Welcome Krishna Polu ! What a great addition to our Bioqube Ventures team! Proud to be part of this family!

Exciting update from Bioqube portfolio company Bicara Therapeutics, congratulations to the team on unveiling their manuscript. Read all about it below. #aacr23 #BFFI
https://lnkd.in/eMAwSuya

Bioqube Ventures is pleased to welcome Bicara Therapeutics to our portfolio, a clinical-stage biotech advancing its lead program BCA101 and its pipeline of investigational candidates to treat solid tumor cancers.

https://lnkd.in/efJAtW9Q

msh id	COM:BIOQUBEVENTURES
symbol	-
name	Anavo Therapeutics
homepage url	https://bioqubeventures.com
country	BE
sector	Healthcare & Health Services
industry	Biotechnology
market	PRIVATE
employee count	13
crunchbase url	https://www.crunchbase.com/organization/anavo-therapeutics
linkedin url	https://www.linkedin.com/company/bioqube-ventures
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	10.36
growth score 28	16.39
growth score 90	14.09
growth score 365	13.03

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

COM:BIOQUBEVENTURES

Anavo Therapeutics

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-